Results 11 to 20 of about 44,945 (292)
Standardization of antifungal susceptibility testing [PDF]
Journal of Antimicrobial Chemotherapy, 1996 The application of in-vitro antifungal susceptibility testing to clinical research and to the guidance of antifungal therapy has been limited by a lack of reproducibility and uncertain clinical relevance. As a result of studies of the identified variables impacting on in-vitro susceptibility results, the National Committee for Clinical Laboratory ...
Martin Cormican, Michael A. Pfaller
+7 more sources
Antifungal susceptibility tests [PDF]
Antimicrobial Agents and Chemotherapy, 1987 J N Galgiani
openalex +5 more sources
In vitro antifungal susceptibility methods and clinical implications of antifungal resistance [PDF]
Medical Mycology, 2000 As new antifungal agents are introduced for the treatment of infections caused by yeasts and filamentous fungi (moulds), it is important that reliable methods are available for the in vitro testing of both new and established agents. The ultimate goal of in vitro testing is the prediction of the clinical outcome of therapy.
Ana Espinel‐Ingroff +3 more
openalex +4 more sources
Antifungal susceptibility testing [PDF]
Clinical Microbiology Reviews, 1993 Unlike antibacterial susceptibility testing, reliable antifungal susceptibility testing is still largely in its infancy. Many methods have been described, but they produce widely discrepant results unless such factors as pH, inoculum size, medium formulation, incubation time, and incubation temperature are carefully controlled.
John N. Galgiani +4 more
openaire +3 more sources
Susceptibility Testing of Fungi to Antifungal Drugs [PDF]
Journal of Fungi, 2018 Susceptibility testing of fungi against antifungal drugs commonly used for therapy is a key component of the care of patients with invasive fungal infections. Antifungal susceptibility testing (AFST) has progressed in recent decades to finally become standardized and available as both Clinical and Laboratory Standards Institute (CLSI) and European ...
Sanguinetti M., Posteraro B.
openaire +4 more sources
Impact of the Disk Diffusion Test on Fluconazole De-Escalation in Patients with Candidemia
Journal of Fungi, 2022 Disk diffusion (DD) is a simple antifungal susceptibility method for Candida. This study examined the impact of fluconazole DD testing on antifungal de-escalation.
Suchavadee Tantasuwan +3 more
doaj +1 more source
Journal of Fungi, 2022 Malassezia yeasts have recently gained medical importance as emerging pathogens associated with a wide range of dermatological and systemic infections.
Wissal Chebil +7 more
doaj +1 more source
Antifungal Susceptibility Testing: A Primer for Clinicians [PDF]
Open Forum Infectious Diseases, 2021 Abstract Clinicians treating patients with fungal infections may turn to susceptibility testing to obtain information regarding the activity of different antifungals against a specific fungus that has been cultured. These results may then be used to make decisions regarding a patient’s therapy.
openaire +3 more sources
BMC Research Notes, 2017 Background Candida species are responsible for various clinical infections ranging from mucocutaneous infection to life threatening invasive diseases along with increased resistance to antifungal drugs has made a serious concern. Resistance to antifungal
Sundar Khadka +12 more
doaj +1 more source
Well diffusion for antifungal susceptibility testing [PDF]
International Journal of Infectious Diseases, 2004 The increasing clinical and microbiologic resistance of Candida spp. isolates to several antifungal agents is becoming a serious problem. It is now reasonable to propose the use of antifungal susceptibility testing in Candida spp. isolates from patients who have failed conventional therapy, before the selection of an empirical therapy.One hundred and ...
María Teresa Colella +6 more
openaire +3 more sources